Related Experiment Videos
Risk stratification by treadmill testing in acute myocardial infarction following thrombolytic therapy
A Banerjee1, N B Debnath, S Roy
1Railway Hospital, Howrah.
The Journal of the Association of Physicians of India
|March 29, 2001
Summary
Treadmill tests (TMT) may not effectively stratify risk for acute myocardial infarction (AMI) survivors in the post-thrombolytic era. This study found TMT parameters were insignificant in predicting future cardiac events in these patients.
Area of Science:
- Cardiology
- Clinical Medicine
- Preventive Cardiology
Background:
- Risk stratification is crucial for acute myocardial infarction (AMI) survivors to predict future cardiovascular events.
- Treadmill testing (TMT) has been a traditional method for risk stratification.
- The efficacy of TMT in the post-thrombolytic era requires re-evaluation, as most existing algorithms predate widespread thrombolysis.
Purpose of the Study:
- To evaluate the effectiveness of symptom-limited treadmill testing (TMT) for risk stratification in male patients surviving acute myocardial infarction (AMI).
- To determine if TMT parameters can predict cardiac events in the post-thrombolytic treatment era.
Main Methods:
- Fifty male AMI survivors (age 38-62) underwent symptom-limited TMT using the Modified Bruce Protocol.
- Patients were followed up for 6-10 months to record cardiac events.
- TMT parameters including ST segment depression, number of leads with ST depression, work capacity (METs), and blood pressure response were compared between groups with and without events.
Main Results:
- Out of 38 patients followed up, 22 experienced cardiac events (Group A) and 16 did not (Group B).
- Statistically insignificant differences were observed between Group A and B in key TMT parameters: ST depression > 2.5 mm (12 vs 9), number of leads with ST depression (66 vs 48), mean work capacity (8.1 vs 7.9 METs), and mean systolic blood pressure response.
- Cardiac events included unstable angina, reinfarction, sudden death, and need for coronary artery bypass grafting or angioplasty.
Conclusions:
- This study suggests that treadmill testing (TMT) may not be a reliable prognostic indicator for risk stratification in acute myocardial infarction (AMI) survivors treated with thrombolysis.
- The efficacy of TMT in predicting future cardiac events in the post-thrombolytic era remains undetermined.
- Further research is needed to establish effective risk stratification methods for contemporary AMI survivors.